CBIZ Investment Advisory Services LLC Has $30,000 Position in Chemed Co. (NYSE:CHE)

CBIZ Investment Advisory Services LLC lifted its stake in shares of Chemed Co. (NYSE:CHEFree Report) by 64.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 56 shares of the company’s stock after acquiring an additional 22 shares during the period. CBIZ Investment Advisory Services LLC’s holdings in Chemed were worth $30,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. CIBC Asset Management Inc increased its stake in Chemed by 5.1% during the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock valued at $242,000 after purchasing an additional 22 shares in the last quarter. EP Wealth Advisors LLC increased its stake in Chemed by 1.9% during the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock valued at $814,000 after purchasing an additional 25 shares in the last quarter. Independent Advisor Alliance increased its stake in Chemed by 1.1% during the 4th quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock valued at $1,207,000 after purchasing an additional 25 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in Chemed by 7.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company’s stock valued at $264,000 after purchasing an additional 33 shares in the last quarter. Finally, Argonautica Private Wealth Management Inc. increased its stake in Chemed by 7.2% during the 4th quarter. Argonautica Private Wealth Management Inc. now owns 505 shares of the company’s stock valued at $268,000 after purchasing an additional 34 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity

In other news, VP Brian C. Judkins bought 145 shares of the stock in a transaction dated Monday, December 30th. The stock was bought at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the acquisition, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. This trade represents a 9.46 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the sale, the chief executive officer now owns 102,679 shares of the company’s stock, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by corporate insiders.

Chemed Price Performance

Shares of CHE stock opened at $598.15 on Friday. The firm has a 50-day moving average of $560.28 and a 200-day moving average of $564.79. The company has a market cap of $8.76 billion, a P/E ratio of 30.22, a P/E/G ratio of 2.15 and a beta of 0.43. Chemed Co. has a one year low of $512.12 and a one year high of $654.62.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.33%. Chemed’s dividend payout ratio is currently 10.05%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CHE. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada boosted their price target on shares of Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a research note on Friday.

Read Our Latest Report on CHE

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

See Also

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.